BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36693178)

  • 1. History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.
    Baker CN
    J Health Polit Policy Law; 2023 Aug; 48(4):485-510. PubMed ID: 36693178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.
    Moseson H; Jayaweera R; Egwuatu I; Grosso B; Kristianingrum IA; Nmezi S; Zurbriggen R; Motana R; Bercu C; Carbone S; Gerdts C
    Lancet Glob Health; 2022 Jan; 10(1):e105-e113. PubMed ID: 34801131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone: A Safe Method of Medical Abortion and Self-Managed Medical Abortion in the Post-Roe Era.
    Schmidt EO; Katz A; Stein RA
    Am J Ther; 2022 Sep-Oct 01; 29(5):e534-e543. PubMed ID: 35994387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
    Johnson DM; Ramaswamy S; Gomperts R
    Contraception; 2024 Mar; 131():110345. PubMed ID: 38049047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of self-managed abortion using misoprostol alone acquired from an online telemedicine service in the United States.
    Johnson DM; Michels-Gualtieri M; Gomperts R; Aiken ARA
    Perspect Sex Reprod Health; 2023 Mar; 55(1):4-11. PubMed ID: 36744631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-managed abortion.
    Conti J; Cahill EP
    Curr Opin Obstet Gynecol; 2019 Dec; 31(6):435-440. PubMed ID: 31693568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.
    Aiken ARA; Starling JE; Gomperts R
    JAMA Netw Open; 2021 May; 4(5):e2111852. PubMed ID: 34019085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States.
    Mark A; Foster AM; Perritt J
    Contraception; 2021 Jul; 104(1):38-42. PubMed ID: 33844980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
    Raifman S; Ralph L; Biggs MA; Grossman D
    Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to abortion care and incidence of attempted self-managed abortion among individuals searching Google for abortion care: A national prospective study.
    Upadhyay UD; Cartwright AF; Grossman D
    Contraception; 2022 Feb; 106():49-56. PubMed ID: 34560051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
    Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Chong E; Shochet T; Raymond E; Platais I; Anger HA; Raidoo S; Soon R; Grant MS; Haskell S; Tocce K; Baldwin MK; Boraas CM; Bednarek PH; Banks J; Coplon L; Thompson F; Priegue E; Winikoff B
    Contraception; 2021 Jul; 104(1):43-48. PubMed ID: 33781762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-clinic and self-managed abortion in Bangladesh: menstrual regulation provider perspectives.
    Crouthamel B; Pearson E; Tilford S; Hurst S; Paul D; Aqtar F; Silverman J; Averbach S
    Reprod Health; 2021 Mar; 18(1):69. PubMed ID: 33766050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
    Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
    BMJ Sex Reprod Health; 2022 Jul; 48(3):185-192. PubMed ID: 34711647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
    Meurice ME; Whitehouse KC; Blaylock R; Chang JJ; Lohr PA
    Contraception; 2021 Jul; 104(1):61-66. PubMed ID: 33974918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessing abortion in a highly restrictive legal regime: characteristics of women and pregnant people in Malta self-managing their abortion through online telemedicine.
    Dibben A; Stabile I; Gomperts R; Kohout J
    BMJ Sex Reprod Health; 2023 Jul; 49(3):176-182. PubMed ID: 36792359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
    Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
    Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote Reproductive Rights.
    Rebouché R
    Am J Law Med; 2022 Jul; 48(2-3):244-255. PubMed ID: 36715252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
    Aultman K; Cirucci CA; Harrison DJ; Beran BD; Lockwood MD; Seiler S
    Issues Law Med; 2021; 36(1):3-26. PubMed ID: 33939340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.